Alison Jones

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 15 EPO patents, primarily in Cancer Treatment Compounds. Top assignees: Mission Therapeutics Limited, Cellzome Limited, Janssen Pharmaceutica Nv. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alison Jones. Retrieved from https://idiyas.com/inventor/alison-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 84.6

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 17)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 39(Granted Patents)

Location History:

Cambridgeshire, GB (2016 - 2017)
Gwynedd, GB (2020)
Cambridge, GB (2012 - 2024)

Company Filing History:

20 out of 34

Mission Therapeutics Limited

Janssen Pharmaceutica Nv

Missions Therapeutics Limited

patent

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

1-Cyano-Pyrrolidine

USP30 Inhibitors

DUB Inhibitors

Cyanopyrrolidine

Cancer Treatment

Heterocyclyl Pyrimidine

TYK2 Inhibitors

Spiro-Condensed Derivatives

Carbon Modulators

Amine Modulators

Pyrazole Derivatives

Deubiquitylating Enzymes

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637426 - 1-cyano-pyrrolidine compounds as USP30 inhibitors (2026-05-26),

2. 11993595 - Compounds (2024-05-28),

3. 11945797 - 1-cyano-pyrrolidine derivatives as dub inhibitors (2024-04-02),

4. 11472798 - Compounds (2022-10-18),

5. 11390584 - 1-cyano-pyrrolidine compounds as USP30 inhibitors (2022-07-19),

6. 11352339 - 1-cyano-pyrrolidine derivatives as DUB inhibitors (2022-06-07),

7. 11319287 - Cyanopyrrolidines as dub inhibitors for the treatment of cancer (2022-05-03),

8. 11306096 - 4,6 dihydropyrrolo [3,4-C] pyrazole-5 (1H)-carbonitrile derivates for treating cancer (2022-04-19),

9. 11236092 - Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors (2022-02-01),

10. 11066365 - 1-cyano-pyrrolidine compounds as USP30 inhibitors (2021-07-20),

11. 11053198 - 1-cyano-pyrrolidine compounds as USP30 inhibitors (2021-07-06),

12. 11014912 - Cyanopyrrolidine derivatives with activity as inhibitors of USP30 (2021-05-25),

13. 10809260 - Method and kit for detection of mycobacteria (2020-10-20),

14. 10774078 - Compounds (2020-09-15),

15. 10689345 - 1-cyano-pyrrolidine compounds as USP30 inhibitors (2020-06-23),

Title: Inventor Alison Jones: Revolutionizing Technology in Cambridge

Introduction: Alison Jones is a pioneering inventor based in Cambridge, GB, known for her groundbreaking contributions to the field of technology.

Latest Patents: Alison Jones holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the tech industry, Alison Jones has led numerous successful projects that have pushed the boundaries of innovation. Her work has been recognized globally for its impact on society.

Collaborations: Throughout her career, Alison Jones has collaborated with leading research institutions, universities, and tech companies to further develop and implement her inventions. Her collaborative spirit has been instrumental in bringing cutting-edge technologies to the market.

Conclusion: Alison Jones continues to inspire the next generation of inventors with her passion for innovation and her dedication to creating a better future through technology. Her contributions to the field will undoubtedly leave a lasting legacy in the world of inventions.

Profile summary based on public USPTO records.